Nanoparticle technology created by researchers at the University of Washington School of Medicine is featured in a vaccine for respiratory syncytial virus (commonly known as RSV).
Among people with HSV-1 genital infections, shedding of the virus declined rapidly during the first year.
UW Medicine is working closely with Public Health–Seattle & King County and the Washington State Department of Health to investigate the case.
First-responders in Jefferson County, Wash., will study an infection-control prototype during simulated patient transports.
Across King County is a great disparity in the health quality of residents in different neighborhoods. Disparities in life expectancy are as high as 18 years for men and 14 years for women.